6019	3861292	empty	patients felt nausea	In@1 one@1 observational@1 single-center@1 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6020	3861292	empty	rosuvastatin 10 mg/day	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6021	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6022	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6023	3861292	empty	very old patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@1 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6024	3861292	empty	All patients	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@1 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@1 TC@1 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6025	3861292	empty	rosuvastatin 10 mg/day	Another@0 trial@0 showed@0 that@0 the@0 efficacy@1 of@1 rosuvastatin@1 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6026	3861292	empty	very elderly patients	One@0 trial@0 also@1 compared@1 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6027	3861292	empty	low	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6028	3861292	empty	atorvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6029	3861292	empty	elderly patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@1 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@1 and@1 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6030	3861292	empty	rosuvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@1 simvastatin@1 and@1 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6031	3861292	empty	simvastatin group	One@0 trial@0 also@1 compared@1 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6032	3861292	empty	simvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6033	3861292	empty	cases over 80 years old , with CHD	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6034	3861292	empty	all the patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6035	3861292	empty	low-dose rosuvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6036	3861292	empty	Chinese patients	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6037	3861292	empty	low	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6038	3861292	empty	Chinese patients with or without hyperlipidemia	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6039	3861292	empty	many kinds of patients , eg , those with hyperlipidemia , acute coronary syndrome , or hypertension	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6040	3861292	empty	control group	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6041	3861292	empty	rosuvastatin group	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6042	3861292	empty	patients with carotid plaque	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6019	3861292	empty	patients felt nausea	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6020	3861292	empty	rosuvastatin 10 mg/day	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6021	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6022	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6023	3861292	empty	very old patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6024	3861292	empty	All patients	Another@1 trial@1 showed@1 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6019	3861292	empty	patients felt nausea	In@1 one@1 observational@1 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6020	3861292	empty	rosuvastatin 10 mg/day	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6021	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6022	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6023	3861292	empty	very old patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6024	3861292	empty	All patients	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6025	3861292	empty	rosuvastatin 10 mg/day	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6026	3861292	empty	very elderly patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6027	3861292	empty	low	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6019	3861292	empty	patients felt nausea	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6020	3861292	empty	rosuvastatin 10 mg/day	In@0 one@0 observational@0 single-center@0 trial@0 ,@0 45@0 patients@0 were@0 enrolled@0 .@0 The@0 patients@0 received@0 rosuvastatin@0 10@0 mg/day@0 for@0 12@0 weeks@0 .@0 Rosuvastatin@0 reduced@0 TC@0 and@0 LDL-C@0 effectively@0 ,@0 and@0 also@0 increased@0 HDL-C@0 ,@0 all@0 P@0 <@0 0.05@0 .@0 Three@0 patients@0 suffered@0 from@0 mild@0 abdomen@0 discomfort@0 and@0 two@0 patients@0 felt@0 nausea@0 ,@0 but@0 no@0 patient@0 discontinued@0 treatment@0 .@0 Creatinine@0 ,@0 alanine@0 transaminase@0 ,@0 and@0 aspartate@0 transaminase@0 levels@0 showed@0 no@0 change@0 after@0 treatment@0 .@0	1@1@2423 2@2@2424 3@3@2425 4@4@2426 5@5@2427 6@6@2428 7@7@2429 8@8@2430 9@9@2431 10@10@2432 11@11@2433 1@12@2434 2@13@2435 3@14@2436 4@15@2437 5@16@2438 6@17@2439 7@18@2440 8@19@2441 9@20@2442 10@21@2443 1@22@2444 2@23@2445 3@24@2446 4@25@2447 5@26@2448 6@27@2449 7@28@2450 8@29@2451 9@30@2452 10@31@2453 11@32@2454 12@33@2455 13@34@2456 14@35@2457 15@36@2458 16@37@2459 17@38@2460 1@39@2461 2@40@2462 3@41@2463 4@42@2464 5@43@2465 6@44@2466 7@45@2467 8@46@2468 9@47@2469 10@48@2470 11@49@2471 12@50@2472 13@51@2473 14@52@2474 15@53@2475 16@54@2476 17@55@2477 18@56@2478 19@57@2479 1@58@2480 2@59@2481 3@60@2482 4@61@2483 5@62@2484 6@63@2485 7@64@2486 8@65@2487 9@66@2488 10@67@2489 11@68@2490 12@69@2491 13@70@2492 14@71@2493 15@72@2494	IN CD JJ JJ NN , CD NNS VBD VBN . DT NNS VBD NN CD NN IN CD NNS . NNP VBD NN CC NN RB , CC RB VBD NN , DT NN JJR CD . CD NNS VBD IN JJ NN NN CC CD NNS VBD NN , CC DT NN VBN NN . NN , NN NN , CC NN NN NNS VBD DT NN IN NN .	case@5 nummod@5 amod@5 amod@5 nmod:in@10 punct@10 nummod@8 nsubjpass@10 auxpass@10 ROOT@0 punct@10 det@2 nsubj@3 ROOT@0 compound@6 nummod@6 dobj@3 case@9 nummod@9 nmod:for@3 punct@3 nsubj@10 ROOT@0 dobj@2 cc@3 conj:and@3 advmod@2 punct@2 cc@2 advmod@10 conj:and@2 dobj@10 punct@2 det@14 dobj@2 amod@14 dep@15 punct@2 nummod@2 nsubj@3 ROOT@0 case@7 amod@7 compound@7 nmod:from@3 cc@7 nummod@10 conj:and@7 dep@3 dobj@11 punct@3 cc@3 neg@16 conj:but@3 amod@18 dobj@16 punct@3 nsubj@10 punct@1 compound@4 nsubj@10 punct@1 cc@1 compound@9 compound@9 nsubj@10 ROOT@0 neg@12 dobj@10 case@14 nmod:after@12 punct@10
6021	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6022	3861292	empty	patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6023	3861292	empty	very old patients with hypercholesterolemia	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6024	3861292	empty	All patients	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@0 2@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 significantly@0 decreased@0 ;@0 after@0 12@0 weeks@0 '@0 treatment@0 with@0 rosuvastatin@0 ,@0 levels@0 of@0 TC@0 and@0 LDL-C@0 decreased@0 more@0 remarkably@0 .@0 All@0 patients@0 showed@0 good@0 compliance@0 and@0 tolerance@0 with@0 rosuvastatin@0 10@0 mg/day@0 .@0 No@0 adverse@0 drug@0 reaction@0 was@0 observed@0 .@0	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6025	3861292	empty	rosuvastatin 10 mg/day	Another@0 trial@0 showed@0 that@0 the@0 efficacy@0 of@0 rosuvastatin@0 10@0 mg/day@0 was@0 observed@0 as@0 early@0 as@0 2@0 weeks@0 and@0 continued@0 to@0 reduce@0 lipids@0 until@0 12@0 weeks@0 .@0 The@0 trial@0 enrolled@0 a@0 total@0 of@0 62@0 very@0 old@0 patients@0 with@0 hypercholesterolemia@0 ,@0 who@0 received@0 rosuvastatin@0 10@0 mg/day@0 .@0 The@0 changes@0 in@0 TC@0 ,@0 TG@0 ,@0 LDL-C@0 ,@0 HDL-C@0 ,@0 ALT@0 ,@0 AST@0 ,@0 creatine@0 kinase@0 ,@0 and@0 creatinine@0 were@0 compared@0 before@0 and@0 after@0 treatment@0 .@0 After@undefined 2@undefined weeks@undefined '@undefined treatment@undefined with@undefined rosuvastatin@undefined ,@undefined levels@undefined of@undefined TC@undefined and@undefined LDL-C@undefined significantly@undefined decreased@undefined ;@undefined after@undefined 12@undefined weeks@undefined '@undefined treatment@undefined with@undefined rosuvastatin@undefined ,@undefined levels@undefined of@undefined TC@undefined and@undefined LDL-C@undefined decreased@undefined more@undefined remarkably@undefined .@undefined All@undefined patients@undefined showed@undefined good@undefined compliance@undefined and@undefined tolerance@undefined with@undefined rosuvastatin@undefined 10@undefined mg/day@undefined .@undefined No@undefined adverse@undefined drug@undefined reaction@undefined was@undefined observed@undefined .@undefined	1@1@2495 2@2@2496 3@3@2497 4@4@2498 5@5@2499 6@6@2500 7@7@2501 8@8@2502 9@9@2503 10@10@2504 11@11@2505 12@12@2506 13@13@2507 14@14@2508 15@15@2509 16@16@2510 17@17@2511 18@18@2512 19@19@2513 20@20@2514 21@21@2515 22@22@2516 23@23@2517 24@24@2518 25@25@2519 26@26@2520 1@27@2521 2@28@2522 3@29@2523 4@30@2524 5@31@2525 6@32@2526 7@33@2527 8@34@2528 9@35@2529 10@36@2530 11@37@2531 12@38@2532 13@39@2533 14@40@2534 15@41@2535 16@42@2536 17@43@2537 18@44@2538 19@45@2539 1@46@2540 2@47@2541 3@48@2542 4@49@2543 5@50@2544 6@51@2545 7@52@2546 8@53@2547 9@54@2548 10@55@2549 11@56@2550 12@57@2551 13@58@2552 14@59@2553 15@60@2554 16@61@2555 17@62@2556 18@63@2557 19@64@2558 20@65@2559 21@66@2560 22@67@2561 23@68@2562 24@69@2563 25@70@2564 26@71@2565 27@72@2566 1@73@2567 2@74@2568 3@75@2569 4@76@2570 5@77@2571 6@78@2572 7@79@2573 8@80@2574 9@81@2575 10@82@2576 11@83@2577 12@84@2578 13@85@2579 14@86@2580 15@87@2581 16@88@2582 17@89@2583 18@90@2584 19@91@2585 20@92@2586 21@93@2587 22@94@2588 23@95@2589 24@96@2590 25@97@2591 26@98@2592 27@99@2593 28@100@2594 29@101@2595 30@102@2596 31@103@2597 32@104@2598 33@105@2599 1@106@2600 2@107@2601 3@108@2602 4@109@2603 5@110@2604 6@111@2605 7@112@2606 8@113@2607 9@114@2608 10@115@2609 11@116@2610 12@117@2611 1@118@2612 2@119@2613 3@120@2614 4@121@2615 5@122@2616 6@123@2617 7@124@2618	DT NN VBD IN DT NN IN NN CD NN VBD VBN RB RB IN CD NNS CC VBD TO VB NNS IN CD NNS . DT NN VBD DT NN IN CD RB JJ NNS IN NN , WP VBD NN CD NN . DT NNS IN NN , NN , NN , NN , NN , NNP , NN NN , CC NN VBD VBN IN CC IN NN . IN CD NNS POS NN IN NN , NNS IN NN CC NN RB VBD : IN CD NNS POS NN IN NN , NNS IN NN CC NN VBD RBR RB . DT NNS VBD JJ NN CC NN IN NN CD NN . DT JJ NN NN VBD VBN .	det@2 nsubj@3 ROOT@0 mark@12 det@6 nsubj:xsubj@21 case@10 compound@10 nummod@10 nmod:of@6 auxpass@12 ccomp@3 advmod@14 advmod@12 case@17 nummod@17 nmod:as@14 cc@12 conj:and@12 mark@21 xcomp@19 dobj@21 case@25 nummod@25 nmod:until@21 punct@3 det@2 nsubj@3 ROOT@0 det:qmod@10 mwe@4 mwe@4 nummod@10 advmod@9 amod@10 nsubj@15 case@12 nmod:with@10 punct@10 ref@10 acl:relcl@10 compound@18 nummod@18 dobj@15 punct@3 det@2 nsubjpass@22 case@4 nmod:in@2 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 conj:and@4 punct@4 compound@17 conj:and@4 punct@4 cc@4 conj:and@4 auxpass@22 ROOT@0 nmod@26 cc@23 nmod@26 nmod@22 punct@22 case@5 nummod@3 nmod:poss@5 case@3 nmod:after@15 case@7 nmod:with@5 punct@15 nsubj@15 case@11 nmod:of@9 cc@11 conj:and@11 advmod@15 ROOT@0 punct@15 case@21 nummod@19 nmod:poss@21 case@19 nmod:after@15 case@23 nmod:with@21 punct@21 nsubj@30 case@27 nmod:of@25 cc@27 conj:and@27 acl:relcl@21 advmod@32 advmod@30 punct@15 det@2 nsubj@3 ROOT@0 amod@5 dobj@3 cc@5 conj:and@5 case@11 compound@11 nummod@11 nmod:with@5 punct@3 neg@4 amod@4 compound@4 nsubjpass@6 auxpass@6 ROOT@0 punct@6
6026	3861292	empty	very elderly patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@undefined follow@undefined up@undefined at@undefined 12@undefined --@undefined 24@undefined months@undefined in@undefined all@undefined the@undefined patients@undefined .@undefined Results@undefined showed@undefined that@undefined the@undefined low@undefined dose@undefined of@undefined rosuvastatin@undefined 5@undefined mg/day@undefined was@undefined as@undefined effective@undefined and@undefined safe@undefined as@undefined the@undefined standard@undefined dosage@undefined of@undefined simvastatin@undefined and@undefined atorvastatin@undefined .@undefined The@undefined reduction@undefined of@undefined TC@undefined and@undefined LDL-C@undefined was@undefined obvious@undefined after@undefined treatment@undefined of@undefined 5@undefined mg/day@undefined rosuvastatin@undefined .@undefined There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6027	3861292	empty	low	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6028	3861292	empty	atorvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6029	3861292	empty	elderly patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@undefined were@undefined few@undefined adverse@undefined events@undefined after@undefined treatment@undefined .@undefined Blood@undefined lipid@undefined parameters@undefined and@undefined safety@undefined profiles@undefined after@undefined treatment@undefined in@undefined the@undefined simvastatin@undefined group@undefined ,@undefined atorvastatin@undefined group@undefined ,@undefined and@undefined low-dose@undefined rosuvastatin@undefined group@undefined were@undefined not@undefined significantly@undefined different@undefined ,@undefined including@undefined CK@undefined and@undefined liver@undefined and@undefined renal@undefined function@undefined .@undefined	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6030	3861292	empty	rosuvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6031	3861292	empty	simvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6032	3861292	empty	simvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6033	3861292	empty	cases over 80 years old , with CHD	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6034	3861292	empty	all the patients	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6035	3861292	empty	low-dose rosuvastatin group	One@0 trial@0 also@0 compared@0 rosuvastatin@0 with@0 simvastatin@0 and@0 atorvastatin@0 in@0 very@0 elderly@0 patients@0 .@0 The@0 trial@0 enrolled@0 a@0 selected@0 73@0 cases@0 over@0 80@0 years@0 old@0 ,@0 with@0 CHD@0 ,@0 who@0 were@0 divided@0 into@0 three@0 groups@0 according@0 to@0 the@0 different@0 statin@0 drugs@0 :@0 27@0 in@0 the@0 simvastatin@0 group@0 ,@0 32@0 in@0 the@0 atorvastatin@0 group@0 ,@0 and@0 14@0 in@0 the@0 rosuvastatin@0 group@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 indicators@0 were@0 monitored@0 before@0 treatment@0 and@0 at@0 follow@0 up@0 at@0 12@0 --@0 24@0 months@0 in@0 all@0 the@0 patients@0 .@0 Results@0 showed@0 that@0 the@0 low@0 dose@0 of@0 rosuvastatin@0 5@0 mg/day@0 was@0 as@0 effective@0 and@0 safe@0 as@0 the@0 standard@0 dosage@0 of@0 simvastatin@0 and@0 atorvastatin@0 .@0 The@0 reduction@0 of@0 TC@0 and@0 LDL-C@0 was@0 obvious@0 after@0 treatment@0 of@0 5@0 mg/day@0 rosuvastatin@0 .@0 There@0 were@0 few@0 adverse@0 events@0 after@0 treatment@0 .@0 Blood@0 lipid@0 parameters@0 and@0 safety@0 profiles@0 after@0 treatment@0 in@0 the@0 simvastatin@0 group@0 ,@0 atorvastatin@0 group@0 ,@0 and@0 low-dose@0 rosuvastatin@0 group@0 were@0 not@0 significantly@0 different@0 ,@0 including@0 CK@0 and@0 liver@0 and@0 renal@0 function@0 .@0	1@1@2619 2@2@2620 3@3@2621 4@4@2622 5@5@2623 6@6@2624 7@7@2625 8@8@2626 9@9@2627 10@10@2628 11@11@2629 12@12@2630 13@13@2631 14@14@2632 1@15@2633 2@16@2634 3@17@2635 4@18@2636 5@19@2637 6@20@2638 7@21@2639 8@22@2640 9@23@2641 10@24@2642 11@25@2643 12@26@2644 13@27@2645 14@28@2646 15@29@2647 16@30@2648 17@31@2649 18@32@2650 19@33@2651 20@34@2652 21@35@2653 22@36@2654 23@37@2655 24@38@2656 25@39@2657 26@40@2658 27@41@2659 28@42@2660 29@43@2661 30@44@2662 31@45@2663 32@46@2664 33@47@2665 34@48@2666 35@49@2667 36@50@2668 37@51@2669 38@52@2670 39@53@2671 40@54@2672 41@55@2673 42@56@2674 43@57@2675 44@58@2676 45@59@2677 46@60@2678 47@61@2679 1@62@2680 2@63@2681 3@64@2682 4@65@2683 5@66@2684 6@67@2685 7@68@2686 8@69@2687 9@70@2688 10@71@2689 11@72@2690 12@73@2691 13@74@2692 14@75@2693 15@76@2694 16@77@2695 17@78@2696 18@79@2697 19@80@2698 20@81@2699 21@82@2700 22@83@2701 23@84@2702 24@85@2703 1@86@2704 2@87@2705 3@88@2706 4@89@2707 5@90@2708 6@91@2709 7@92@2710 8@93@2711 9@94@2712 10@95@2713 11@96@2714 12@97@2715 13@98@2716 14@99@2717 15@100@2718 16@101@2719 17@102@2720 18@103@2721 19@104@2722 20@105@2723 21@106@2724 22@107@2725 23@108@2726 24@109@2727 1@110@2728 2@111@2729 3@112@2730 4@113@2731 5@114@2732 6@115@2733 7@116@2734 8@117@2735 9@118@2736 10@119@2737 11@120@2738 12@121@2739 13@122@2740 14@123@2741 15@124@2742 1@125@2743 2@126@2744 3@127@2745 4@128@2746 5@129@2747 6@130@2748 7@131@2749 8@132@2750 1@133@2751 2@134@2752 3@135@2753 4@136@2754 5@137@2755 6@138@2756 7@139@2757 8@140@2758 9@141@2759 10@142@2760 11@143@2761 12@144@2762 13@145@2763 14@146@2764 15@147@2765 16@148@2766 17@149@2767 18@150@2768 19@151@2769 20@152@2770 21@153@2771 22@154@2772 23@155@2773 24@156@2774 25@157@2775 26@158@2776 27@159@2777 28@160@2778 29@161@2779 30@162@2780 31@163@2781 32@164@2782 33@165@2783	CD NN RB VBN NN IN NN CC NN IN RB JJ NNS . DT NN VBD DT VBN CD NNS IN CD NNS JJ , IN NN , WP VBD VBN IN CD NNS VBG TO DT JJ NN NNS : CD IN DT NN NN , CD IN DT NN NN , CC CD IN DT NN NN . NN NN NNS CC NN NNS VBD VBN IN NN CC IN VB RP IN CD : CD NNS IN PDT DT NNS . NNS VBD IN DT JJ NN IN NN CD NN VBD IN JJ CC JJ IN DT JJ NN IN NN CC NN . DT NN IN NN CC NN VBD JJ IN NN IN CD NN NN . EX VBD JJ JJ NNS IN NN . NN NN NNS CC NN NNS IN NN IN DT NN NN , NN NN , CC JJ NN NN VBD RB RB JJ , VBG NNP CC NN CC JJ NN .	nummod@2 nsubj@4 advmod@4 ROOT@0 dobj@4 case@7 nmod:with@5 cc@7 conj:and@7 case@13 advmod@12 amod@13 nmod:in@5 punct@4 det@2 nsubj@3 ROOT@0 det@7 amod@7 nummod@7 dobj@3 case@10 nummod@10 nmod:over@3 amod@10 punct@3 case@14 nsubjpass@18 punct@14 ref@14 auxpass@18 acl:relcl@14 case@21 nummod@21 nmod:into@18 case@27 mwe@22 det@27 amod@27 compound@27 nmod:according_to@18 punct@3 dep@3 case@33 det@33 compound@33 nmod:in@29 punct@29 conj:and@29 case@39 det@39 compound@39 nmod:in@35 punct@29 cc@29 conj:and@29 case@46 det@46 compound@46 nmod:in@29 punct@3 compound@3 compound@3 nsubj@13 cc@3 compound@6 nsubjpass@8 auxpass@8 ROOT@0 case@10 nmod:before@8 cc@8 mark@13 conj:and@8 compound:prt@13 case@16 nmod:at@13 punct@16 nummod@19 dep@16 case@23 det:predet@23 det@23 nmod:in@19 punct@8 nsubj@2 ROOT@0 mark@13 det@6 amod@6 nsubj@15 case@10 compound@10 nummod@10 nmod:of@6 cop@13 advmod@13 ccomp@2 cc@13 conj:and@13 case@19 det@19 amod@19 nmod:as@13 case@21 nmod:of@19 cc@21 conj:and@21 punct@2 det@2 nsubj@8 case@4 nmod:of@2 cc@4 conj:and@4 cop@8 ROOT@0 case@10 nmod:after@8 case@14 nummod@14 compound@14 nmod:of@10 punct@8 expl@2 ROOT@0 amod@5 amod@5 nsubj@2 case@7 nmod:after@5 punct@2 compound@3 compound@3 nsubj@24 cc@3 compound@6 nsubj@24 case@8 nmod:after@3 case@12 det@12 compound@12 nmod:in@8 punct@3 compound@15 nsubj@24 punct@3 cc@3 amod@20 compound@20 nsubj@24 cop@24 neg@24 advmod@24 ROOT@0 punct@24 case@27 nmod:including@24 cc@27 conj:and@27 cc@27 amod@32 conj:and@27 punct@24
6036	3861292	empty	Chinese patients	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6037	3861292	empty	low	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6038	3861292	empty	Chinese patients with or without hyperlipidemia	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6039	3861292	empty	many kinds of patients , eg , those with hyperlipidemia , acute coronary syndrome , or hypertension	Rosuvastatin@0 is@0 an@0 aggressive@0 lipid-lowering@0 drug@0 ;@0 it@0 has@0 been@0 confirmed@0 in@0 small@0 trials@0 to@0 be@0 effective@0 in@0 treating@0 carotid@0 atherosclerosis@0 in@0 Chinese@0 patients@0 with@0 or@0 without@0 hyperlipidemia.@0 ,@0 It@0 also@0 has@0 anti-inflammatory@0 and@0 antiatherosclerosis@0 effects@0 in@0 many@0 kinds@0 of@0 patients@0 ,@0 eg@0 ,@0 those@0 with@0 hyperlipidemia@0 ,@0 acute@0 coronary@0 syndrome@0 ,@0 or@0 hypertension@0 .@0 The@0 effect@0 is@0 dose-dependent@0 ,@0 and@0 there@0 are@0 no@0 serious@0 adverse@0 events@0 ,@0 even@0 at@0 20@0 mg/day@0 .@0	1@1@2822 2@2@2823 3@3@2824 4@4@2825 5@5@2826 6@6@2827 7@7@2828 8@8@2829 9@9@2830 10@10@2831 11@11@2832 12@12@2833 13@13@2834 14@14@2835 15@15@2836 16@16@2837 17@17@2838 18@18@2839 19@19@2840 20@20@2841 21@21@2842 22@22@2843 23@23@2844 24@24@2845 25@25@2846 26@26@2847 27@27@2848 28@28@2849 29@29@2850 30@30@2851 31@31@2852 32@32@2853 33@33@2854 34@34@2855 35@35@2856 36@36@2857 37@37@2858 38@38@2859 39@39@2860 40@40@2861 41@41@2862 42@42@2863 43@43@2864 44@44@2865 45@45@2866 46@46@2867 47@47@2868 48@48@2869 49@49@2870 50@50@2871 51@51@2872 52@52@2873 53@53@2874 54@54@2875 55@55@2876 1@56@2877 2@57@2878 3@58@2879 4@59@2880 5@60@2881 6@61@2882 7@62@2883 8@63@2884 9@64@2885 10@65@2886 11@66@2887 12@67@2888 13@68@2889 14@69@2890 15@70@2891 16@71@2892 17@72@2893 18@73@2894	NNP VBZ DT JJ JJ NN : PRP VBZ VBN VBN IN JJ NNS TO VB JJ IN VBG NN NN IN JJ NNS IN CC IN NN , PRP RB VBZ JJ CC JJ NNS IN JJ NNS IN NNS , FW , DT IN NN , JJ JJ NN , CC NN . DT NN VBZ JJ , CC EX VBP DT JJ JJ NNS , RB IN CD NN .	nsubj@6 cop@6 det@6 amod@6 amod@6 ROOT@0 punct@6 nsubj:xsubj@17 aux@11 auxpass@11 parataxis@6 case@14 amod@14 nmod:in@11 mark@17 cop@17 xcomp@11 mark@19 advcl:in@17 compound@21 dobj@19 case@24 amod@24 nmod:in@19 nmod@28 cc@25 nmod@28 nmod@24 punct@11 nsubj@32 advmod@32 parataxis@11 amod@36 cc@33 amod@36 dobj@32 case@39 amod@39 nmod:in@32 case@41 nmod:of@39 punct@39 dep@39 punct@43 root@44 case@47 nmod:with@45 punct@47 amod@51 amod@51 conj:or@47 punct@47 cc@47 conj:or@47 punct@45 det@2 nsubj@4 cop@4 ROOT@0 punct@4 cc@4 expl@8 conj:and@4 neg@12 amod@12 amod@12 nsubj@8 punct@8 advmod@17 case@17 nummod@17 nmod:at@8 punct@4
6040	3861292	empty	control group	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6041	3861292	empty	rosuvastatin group	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6042	3861292	empty	patients with carotid plaque	One@0 controlled@0 trial@0 enrolled@0 40@0 patients@0 with@0 carotid@0 plaque@0 receiving@0 rosuvastatin@0 10@0 mg@0 and@0 placebo@0 for@0 12@0 months@0 .@0 Total@0 plaque@0 numbers@0 showed@0 no@0 significant@0 change@0 in@0 either@0 group@0 ,@0 while@0 plaque@0 thickness@0 reduced@0 significantly@0 from@0 1.92@0 @0 0.53@0 mm@0 to@0 1.10@0 @0 0.50@0 mm@0 in@0 the@0 rosuvastatin@0 group@0 ,@0 and@0 74.5@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 .@0 Meanwhile@0 ,@0 plaque@0 thickness@0 increased@0 from@0 1.60@0 @0 0.37@0 mm@0 to@0 1.72@0 @0 0.38@0 mm@0 ,@0 and@0 15.7@0 %@0 of@0 soft@0 plaques@0 changed@0 into@0 hard@0 plaques@0 in@0 the@0 control@0 group@0 .@0	1@1@2895 2@2@2896 3@3@2897 4@4@2898 5@5@2899 6@6@2900 7@7@2901 8@8@2902 9@9@2903 10@10@2904 11@11@2905 12@12@2906 13@13@2907 14@14@2908 15@15@2909 16@16@2910 17@17@2911 18@18@2912 19@19@2913 1@20@2914 2@21@2915 3@22@2916 4@23@2917 5@24@2918 6@25@2919 7@26@2920 8@27@2921 9@28@2922 10@29@2923 11@30@2924 12@31@2925 13@32@2926 14@33@2927 15@34@2928 16@35@2929 17@36@2930 18@37@2931 19@38@2932 20@39@2933 21@40@2934 22@41@2935 23@42@2936 24@43@2937 25@44@2938 26@45@2939 27@46@2940 28@47@2941 29@48@2942 30@49@2943 31@50@2944 32@51@2945 33@52@2946 34@53@2947 35@54@2948 36@55@2949 37@56@2950 38@57@2951 39@58@2952 40@59@2953 41@60@2954 42@61@2955 1@62@2956 2@63@2957 3@64@2958 4@65@2959 5@66@2960 6@67@2961 7@68@2962 8@69@2963 9@70@2964 10@71@2965 11@72@2966 12@73@2967 13@74@2968 14@75@2969 15@76@2970 16@77@2971 17@78@2972 18@79@2973 19@80@2974 20@81@2975 21@82@2976 22@83@2977 23@84@2978 24@85@2979 25@86@2980 26@87@2981 27@88@2982 28@89@2983 29@90@2984 30@91@2985 31@92@2986	CD JJ NN VBD CD NNS IN NN NN VBG NN CD NN CC NN IN CD NNS . JJ NN NNS VBD DT JJ NN IN CC NN , IN NN NN VBD RB IN CD CD CD NN TO CD CD CD NN IN DT NN NN , CC CD NN IN JJ NNS VBD IN JJ NNS . RB , NN NN VBN IN CD CD CD NN TO CD CD CD NN , CC CD NN IN JJ NNS VBD IN JJ NNS IN DT NN NN .	nummod@3 amod@3 nsubj@4 ROOT@0 nummod@6 dobj@4 case@9 compound@9 nmod:with@6 acl@6 compound@13 nummod@13 dobj@10 cc@13 conj:and@13 case@18 nummod@18 nmod:for@10 punct@4 amod@3 compound@3 nsubj@4 ROOT@0 neg@7 amod@7 dobj@4 case@10 det@10 nmod:in@7 punct@4 mark@15 compound@14 nsubj@15 advcl:while@4 advmod@15 case@21 compound@19 nummod@21 nummod@21 nmod:from@15 case@26 compound@25 compound@25 nummod@26 nmod:to@21 case@30 det@30 compound@30 nmod:in@21 punct@21 cc@21 nummod@34 nsubj@38 case@37 amod@37 nmod:of@34 conj:and@21 case@41 amod@41 nmod:into@38 punct@4 advmod@5 punct@5 compound@4 nsubj@5 ROOT@0 case@10 compound@8 nummod@10 nummod@10 nmod:from@5 case@15 compound@14 compound@14 nummod@15 nmod:to@5 punct@5 cc@5 nummod@19 nsubj@23 case@22 amod@22 nmod:of@19 conj:and@5 case@26 amod@26 nmod:into@23 case@30 det@30 compound@30 nmod:in@23 punct@5
6043	3861292	empty	acute coronary syndrome patients	Another@0 trial@0 enrolled@0 70@0 acute@0 coronary@0 syndrome@0 patients@0 .@0 There@0 were@0 13@0 cases@0 of@0 acute@0 myocardial@0 infarction@0 ,@0 and@0 57@0 cases@0 of@0 unstable@0 angina@0 .@0 The@0 patients@0 also@0 had@0 documented@0 carotid@0 atherosclerosis@0 plaque@0 without@0 statin@0 therapy@0 in@0 the@0 last@0 few@0 months@0 .@0 The@0 patients@0 were@0 given@0 rosuvastatin@0 10@0 mg@0 per@0 night@0 for@0 6@0 months@0 .@0 The@0 result@0 of@0 the@0 study@0 showed@0 that@0 rosuvastatin@0 10@0 mg@0 was@0 observed@0 to@0 stabi-lized@0 plaque@0 ,@0 significantly@0 reducing@0 IMT@0 and@0 carotid@0 plaque@0 areas@0 ,@0 accompanied@0 by@0 significant@0 decreases@0 in@0 serum@0 level@0 of@0 TC@0 ,@0 LDL-C@0 ,@0 and@0 high-sensitivity@0 C-reactive@0 protein@0 .@0	1@1@2987 2@2@2988 3@3@2989 4@4@2990 5@5@2991 6@6@2992 7@7@2993 8@8@2994 9@9@2995 1@10@2996 2@11@2997 3@12@2998 4@13@2999 5@14@3000 6@15@3001 7@16@3002 8@17@3003 9@18@3004 10@19@3005 11@20@3006 12@21@3007 13@22@3008 14@23@3009 15@24@3010 16@25@3011 1@26@3012 2@27@3013 3@28@3014 4@29@3015 5@30@3016 6@31@3017 7@32@3018 8@33@3019 9@34@3020 10@35@3021 11@36@3022 12@37@3023 13@38@3024 14@39@3025 15@40@3026 16@41@3027 17@42@3028 1@43@3029 2@44@3030 3@45@3031 4@46@3032 5@47@3033 6@48@3034 7@49@3035 8@50@3036 9@51@3037 10@52@3038 11@53@3039 12@54@3040 13@55@3041 1@56@3042 2@57@3043 3@58@3044 4@59@3045 5@60@3046 6@61@3047 7@62@3048 8@63@3049 9@64@3050 10@65@3051 11@66@3052 12@67@3053 13@68@3054 14@69@3055 15@70@3056 16@71@3057 17@72@3058 18@73@3059 19@74@3060 20@75@3061 21@76@3062 22@77@3063 23@78@3064 24@79@3065 25@80@3066 26@81@3067 27@82@3068 28@83@3069 29@84@3070 30@85@3071 31@86@3072 32@87@3073 33@88@3074 34@89@3075 35@90@3076 36@91@3077 37@92@3078 38@93@3079 39@94@3080 40@95@3081 41@96@3082	DT NN VBD CD JJ JJ NN NNS . EX VBD CD NNS IN JJ JJ NN , CC CD NNS IN JJ NN . DT NNS RB VBD VBN NN NN NN IN NN NN IN DT JJ JJ NNS . DT NNS VBD VBN NN CD NN IN NN IN CD NNS . DT NN IN DT NN VBD IN NN CD NN VBD VBN TO JJ NN , RB VBG NNP CC NN NN NNS , VBN IN JJ NNS IN NN NN IN NN , NN , CC JJ JJ NN .	det@2 nsubj@3 ROOT@0 nummod@8 amod@8 amod@8 compound@8 dobj@3 punct@3 expl@2 ROOT@0 nummod@4 nsubj@2 case@8 amod@8 amod@8 nmod:of@4 punct@2 cc@2 nummod@12 conj:and@2 case@15 amod@15 nmod:of@12 punct@2 det@2 nsubj@5 advmod@5 aux@5 ROOT@0 compound@8 compound@8 dobj@5 case@11 compound@11 nmod:without@5 case@16 det@16 amod@16 amod@16 nmod:in@5 punct@5 det@2 nsubjpass@4 auxpass@4 ROOT@0 compound@7 nummod@7 dobj@4 case@9 nmod:per@7 case@12 nummod@12 nmod:for@4 punct@4 det@2 nsubj@6 case@5 det@5 nmod:of@2 ROOT@0 mark@12 compound@10 nummod@10 nsubjpass@12 auxpass@12 ccomp@6 case@15 amod@15 nmod:to@12 punct@12 advmod@18 xcomp@12 compound@23 cc@19 compound@23 compound@23 dobj@18 punct@18 dep@18 case@28 amod@28 nmod:by@25 case@31 compound@31 nmod:in@28 case@33 nmod:of@31 punct@33 conj:and@33 punct@33 cc@33 amod@40 amod@40 conj:and@33 punct@6		c
6044	3861292	empty	cases of acute myocardial infarction	Another@0 trial@0 enrolled@0 70@0 acute@0 coronary@0 syndrome@0 patients@0 .@0 There@0 were@0 13@0 cases@0 of@0 acute@0 myocardial@0 infarction@0 ,@0 and@0 57@0 cases@0 of@0 unstable@0 angina@0 .@0 The@0 patients@0 also@0 had@0 documented@0 carotid@0 atherosclerosis@0 plaque@0 without@0 statin@0 therapy@0 in@0 the@0 last@0 few@0 months@0 .@0 The@0 patients@0 were@0 given@0 rosuvastatin@0 10@0 mg@0 per@0 night@0 for@0 6@0 months@0 .@0 The@0 result@0 of@0 the@0 study@0 showed@0 that@0 rosuvastatin@0 10@0 mg@0 was@0 observed@0 to@0 stabi-lized@0 plaque@0 ,@0 significantly@0 reducing@0 IMT@0 and@0 carotid@0 plaque@0 areas@0 ,@0 accompanied@0 by@0 significant@0 decreases@0 in@0 serum@0 level@0 of@0 TC@0 ,@0 LDL-C@0 ,@0 and@0 high-sensitivity@0 C-reactive@0 protein@0 .@0	1@1@2987 2@2@2988 3@3@2989 4@4@2990 5@5@2991 6@6@2992 7@7@2993 8@8@2994 9@9@2995 1@10@2996 2@11@2997 3@12@2998 4@13@2999 5@14@3000 6@15@3001 7@16@3002 8@17@3003 9@18@3004 10@19@3005 11@20@3006 12@21@3007 13@22@3008 14@23@3009 15@24@3010 16@25@3011 1@26@3012 2@27@3013 3@28@3014 4@29@3015 5@30@3016 6@31@3017 7@32@3018 8@33@3019 9@34@3020 10@35@3021 11@36@3022 12@37@3023 13@38@3024 14@39@3025 15@40@3026 16@41@3027 17@42@3028 1@43@3029 2@44@3030 3@45@3031 4@46@3032 5@47@3033 6@48@3034 7@49@3035 8@50@3036 9@51@3037 10@52@3038 11@53@3039 12@54@3040 13@55@3041 1@56@3042 2@57@3043 3@58@3044 4@59@3045 5@60@3046 6@61@3047 7@62@3048 8@63@3049 9@64@3050 10@65@3051 11@66@3052 12@67@3053 13@68@3054 14@69@3055 15@70@3056 16@71@3057 17@72@3058 18@73@3059 19@74@3060 20@75@3061 21@76@3062 22@77@3063 23@78@3064 24@79@3065 25@80@3066 26@81@3067 27@82@3068 28@83@3069 29@84@3070 30@85@3071 31@86@3072 32@87@3073 33@88@3074 34@89@3075 35@90@3076 36@91@3077 37@92@3078 38@93@3079 39@94@3080 40@95@3081 41@96@3082	DT NN VBD CD JJ JJ NN NNS . EX VBD CD NNS IN JJ JJ NN , CC CD NNS IN JJ NN . DT NNS RB VBD VBN NN NN NN IN NN NN IN DT JJ JJ NNS . DT NNS VBD VBN NN CD NN IN NN IN CD NNS . DT NN IN DT NN VBD IN NN CD NN VBD VBN TO JJ NN , RB VBG NNP CC NN NN NNS , VBN IN JJ NNS IN NN NN IN NN , NN , CC JJ JJ NN .	det@2 nsubj@3 ROOT@0 nummod@8 amod@8 amod@8 compound@8 dobj@3 punct@3 expl@2 ROOT@0 nummod@4 nsubj@2 case@8 amod@8 amod@8 nmod:of@4 punct@2 cc@2 nummod@12 conj:and@2 case@15 amod@15 nmod:of@12 punct@2 det@2 nsubj@5 advmod@5 aux@5 ROOT@0 compound@8 compound@8 dobj@5 case@11 compound@11 nmod:without@5 case@16 det@16 amod@16 amod@16 nmod:in@5 punct@5 det@2 nsubjpass@4 auxpass@4 ROOT@0 compound@7 nummod@7 dobj@4 case@9 nmod:per@7 case@12 nummod@12 nmod:for@4 punct@4 det@2 nsubj@6 case@5 det@5 nmod:of@2 ROOT@0 mark@12 compound@10 nummod@10 nsubjpass@12 auxpass@12 ccomp@6 case@15 amod@15 nmod:to@12 punct@12 advmod@18 xcomp@12 compound@23 cc@19 compound@23 compound@23 dobj@18 punct@18 dep@18 case@28 amod@28 nmod:by@25 case@31 compound@31 nmod:in@28 case@33 nmod:of@31 punct@33 conj:and@33 punct@33 cc@33 amod@40 amod@40 conj:and@33 punct@6		c
6045	3861292	empty	cases of unstable angina	Another@0 trial@0 enrolled@0 70@0 acute@0 coronary@0 syndrome@0 patients@0 .@0 There@0 were@0 13@0 cases@0 of@0 acute@0 myocardial@0 infarction@0 ,@0 and@0 57@0 cases@0 of@0 unstable@0 angina@0 .@0 The@0 patients@0 also@0 had@0 documented@0 carotid@0 atherosclerosis@0 plaque@0 without@0 statin@0 therapy@0 in@0 the@0 last@0 few@0 months@0 .@0 The@0 patients@0 were@0 given@0 rosuvastatin@0 10@0 mg@0 per@0 night@0 for@0 6@0 months@0 .@0 The@0 result@0 of@0 the@0 study@0 showed@0 that@0 rosuvastatin@0 10@0 mg@0 was@0 observed@0 to@0 stabi-lized@0 plaque@0 ,@0 significantly@0 reducing@0 IMT@0 and@0 carotid@0 plaque@0 areas@0 ,@0 accompanied@0 by@0 significant@0 decreases@0 in@0 serum@0 level@0 of@0 TC@0 ,@0 LDL-C@0 ,@0 and@0 high-sensitivity@0 C-reactive@0 protein@0 .@0	1@1@2987 2@2@2988 3@3@2989 4@4@2990 5@5@2991 6@6@2992 7@7@2993 8@8@2994 9@9@2995 1@10@2996 2@11@2997 3@12@2998 4@13@2999 5@14@3000 6@15@3001 7@16@3002 8@17@3003 9@18@3004 10@19@3005 11@20@3006 12@21@3007 13@22@3008 14@23@3009 15@24@3010 16@25@3011 1@26@3012 2@27@3013 3@28@3014 4@29@3015 5@30@3016 6@31@3017 7@32@3018 8@33@3019 9@34@3020 10@35@3021 11@36@3022 12@37@3023 13@38@3024 14@39@3025 15@40@3026 16@41@3027 17@42@3028 1@43@3029 2@44@3030 3@45@3031 4@46@3032 5@47@3033 6@48@3034 7@49@3035 8@50@3036 9@51@3037 10@52@3038 11@53@3039 12@54@3040 13@55@3041 1@56@3042 2@57@3043 3@58@3044 4@59@3045 5@60@3046 6@61@3047 7@62@3048 8@63@3049 9@64@3050 10@65@3051 11@66@3052 12@67@3053 13@68@3054 14@69@3055 15@70@3056 16@71@3057 17@72@3058 18@73@3059 19@74@3060 20@75@3061 21@76@3062 22@77@3063 23@78@3064 24@79@3065 25@80@3066 26@81@3067 27@82@3068 28@83@3069 29@84@3070 30@85@3071 31@86@3072 32@87@3073 33@88@3074 34@89@3075 35@90@3076 36@91@3077 37@92@3078 38@93@3079 39@94@3080 40@95@3081 41@96@3082	DT NN VBD CD JJ JJ NN NNS . EX VBD CD NNS IN JJ JJ NN , CC CD NNS IN JJ NN . DT NNS RB VBD VBN NN NN NN IN NN NN IN DT JJ JJ NNS . DT NNS VBD VBN NN CD NN IN NN IN CD NNS . DT NN IN DT NN VBD IN NN CD NN VBD VBN TO JJ NN , RB VBG NNP CC NN NN NNS , VBN IN JJ NNS IN NN NN IN NN , NN , CC JJ JJ NN .	det@2 nsubj@3 ROOT@0 nummod@8 amod@8 amod@8 compound@8 dobj@3 punct@3 expl@2 ROOT@0 nummod@4 nsubj@2 case@8 amod@8 amod@8 nmod:of@4 punct@2 cc@2 nummod@12 conj:and@2 case@15 amod@15 nmod:of@12 punct@2 det@2 nsubj@5 advmod@5 aux@5 ROOT@0 compound@8 compound@8 dobj@5 case@11 compound@11 nmod:without@5 case@16 det@16 amod@16 amod@16 nmod:in@5 punct@5 det@2 nsubjpass@4 auxpass@4 ROOT@0 compound@7 nummod@7 dobj@4 case@9 nmod:per@7 case@12 nummod@12 nmod:for@4 punct@4 det@2 nsubj@6 case@5 det@5 nmod:of@2 ROOT@0 mark@12 compound@10 nummod@10 nsubjpass@12 auxpass@12 ccomp@6 case@15 amod@15 nmod:to@12 punct@12 advmod@18 xcomp@12 compound@23 cc@19 compound@23 compound@23 dobj@18 punct@18 dep@18 case@28 amod@28 nmod:by@25 case@31 compound@31 nmod:in@28 case@33 nmod:of@31 punct@33 conj:and@33 punct@33 cc@33 amod@40 amod@40 conj:and@33 punct@6		c
6046	3861292	empty	patients with essential hypertension	One@0 study@0 showed@0 rosuvastatin@0 on@0 the@0 basis@0 of@0 conventional@0 antihypertensive@0 drug@0 treatment@0 produced@0 significant@0 reduction@0 of@0 the@0 levels@0 of@0 microalbuminuria@0 ,@1 IMT@1 ,@1 and@1 coronary@1 calcium@0 score@0 in@0 patients@0 with@0 essential@0 hypertension@0 .@0 A@0 total@0 of@0 76@0 hypertensive@0 patients@0 were@0 randomly@0 selected@0 to@0 receive@0 conventional@0 antihypertensive@0 drugs@0 or@0 rosuvastatin@0 on@0 the@0 top@0 of@0 conventional@0 antihypertensive@0 drugs@0 .@0 Blood@0 pressure@0 ,@0 levels@0 of@0 microalbuminuria@0 ,@0 echocardiography@0 and@0 helical@0 computerized@0 tomography@0 were@0 examined@0 .@0 After@0 8@0 months@0 of@0 treatment@0 ,@0 combined@0 treatment@0 significantly@0 reduced@0 the@0 levels@0 of@0 microalbuminuria@0 ,@0 IMT@0 of@0 the@0 common@0 carotid@0 artery@0 ,@0 and@0 CS@0 .@0 No@0 effect@0 on@0 levels@0 of@0 microalbuminuria@0 ,@0 IMT@0 ,@0 or@0 CS@0 by@0 conventional@0 antihypertensive@0 drugs@0 was@0 found@0 .@0	1@1@3083 2@2@3084 3@3@3085 4@4@3086 5@5@3087 6@6@3088 7@7@3089 8@8@3090 9@9@3091 10@10@3092 11@11@3093 12@12@3094 13@13@3095 14@14@3096 15@15@3097 16@16@3098 17@17@3099 18@18@3100 19@19@3101 20@20@3102 21@21@3103 22@22@3104 23@23@3105 24@24@3106 25@25@3107 26@26@3108 27@27@3109 28@28@3110 29@29@3111 30@30@3112 31@31@3113 32@32@3114 33@33@3115 1@34@3116 2@35@3117 3@36@3118 4@37@3119 5@38@3120 6@39@3121 7@40@3122 8@41@3123 9@42@3124 10@43@3125 11@44@3126 12@45@3127 13@46@3128 14@47@3129 15@48@3130 16@49@3131 17@50@3132 18@51@3133 19@52@3134 20@53@3135 21@54@3136 22@55@3137 23@56@3138 24@57@3139 1@58@3140 2@59@3141 3@60@3142 4@61@3143 5@62@3144 6@63@3145 7@64@3146 8@65@3147 9@66@3148 10@67@3149 11@68@3150 12@69@3151 13@70@3152 14@71@3153 15@72@3154 1@73@3155 2@74@3156 3@75@3157 4@76@3158 5@77@3159 6@78@3160 7@79@3161 8@80@3162 9@81@3163 10@82@3164 11@83@3165 12@84@3166 13@85@3167 14@86@3168 15@87@3169 16@88@3170 17@89@3171 18@90@3172 19@91@3173 20@92@3174 21@93@3175 22@94@3176 23@95@3177 24@96@3178 25@97@3179 1@98@3180 2@99@3181 3@100@3182 4@101@3183 5@102@3184 6@103@3185 7@104@3186 8@105@3187 9@106@3188 10@107@3189 11@108@3190 12@109@3191 13@110@3192 14@111@3193 15@112@3194 16@113@3195 17@114@3196 18@115@3197	CD NN VBD NN IN DT NN IN JJ JJ NN NN VBD JJ NN IN DT NNS IN NN , NNP , CC JJ NN NN IN NNS IN JJ NN . DT NN IN CD JJ NNS VBD RB VBN TO VB JJ JJ NNS CC NN IN DT NN IN JJ JJ NNS . NN NN , NNS IN NN , NN CC JJ JJ NN VBD VBN . IN CD NNS IN NN , JJ NN RB VBD DT NNS IN NN , NN IN DT JJ NN NN , CC NNP . DT NN IN NNS IN NN , NNP , CC NN IN JJ JJ NNS VBD VBN .	nummod@2 nsubj@3 ROOT@0 nsubj@13 case@7 det@7 nmod:on@4 case@12 amod@12 amod@12 compound@12 nmod:of@7 ccomp@3 amod@15 dobj@13 case@18 det@18 nmod:of@15 case@20 nmod:of@18 punct@20 conj:and@20 punct@20 cc@20 amod@27 compound@27 conj:and@20 case@29 nmod:in@20 case@32 amod@32 nmod:with@29 punct@3 det:qmod@6 mwe@1 mwe@1 nummod@6 amod@6 nsubj:xsubj@11 auxpass@9 advmod@9 ROOT@0 mark@11 xcomp@9 amod@14 amod@14 dobj@11 cc@14 conj:or@14 case@19 det@19 nmod:on@11 case@23 amod@23 amod@23 nmod:of@19 punct@9 compound@2 nsubjpass@14 punct@2 appos@2 case@6 nmod:of@4 punct@6 conj:and@6 cc@6 amod@12 amod@12 conj:and@6 auxpass@14 ROOT@0 punct@14 case@3 nummod@3 nmod:after@10 case@5 nmod:of@3 punct@10 amod@8 nsubj@10 advmod@10 ROOT@0 det@12 dobj@10 case@14 nmod:of@12 punct@14 conj:and@14 case@21 det@21 amod@21 compound@21 nmod:of@16 punct@14 cc@14 conj:and@14 punct@10 neg@2 nsubjpass@17 case@4 nmod:on@2 case@6 nmod:of@4 punct@6 conj:or@6 punct@6 cc@6 conj:or@6 case@15 amod@15 amod@15 nmod:by@2 auxpass@17 ROOT@0 punct@17		c
6047	3861292	empty	hypertensive patients	One@1 study@1 showed@1 rosuvastatin@1 on@0 the@0 basis@0 of@0 conventional@0 antihypertensive@0 drug@0 treatment@0 produced@0 significant@0 reduction@0 of@0 the@0 levels@0 of@0 microalbuminuria@0 ,@0 IMT@0 ,@0 and@0 coronary@0 calcium@0 score@0 in@0 patients@0 with@0 essential@0 hypertension@0 .@0 A@0 total@0 of@0 76@0 hypertensive@0 patients@0 were@0 randomly@0 selected@0 to@0 receive@0 conventional@0 antihypertensive@0 drugs@0 or@0 rosuvastatin@0 on@0 the@0 top@0 of@0 conventional@0 antihypertensive@0 drugs@0 .@0 Blood@0 pressure@0 ,@0 levels@0 of@0 microalbuminuria@0 ,@0 echocardiography@0 and@0 helical@0 computerized@0 tomography@0 were@0 examined@0 .@0 After@0 8@0 months@0 of@0 treatment@0 ,@0 combined@0 treatment@0 significantly@0 reduced@0 the@0 levels@0 of@0 microalbuminuria@0 ,@0 IMT@0 of@0 the@0 common@0 carotid@0 artery@0 ,@0 and@0 CS@0 .@0 No@0 effect@0 on@0 levels@0 of@0 microalbuminuria@0 ,@0 IMT@0 ,@0 or@0 CS@0 by@0 conventional@0 antihypertensive@0 drugs@0 was@0 found@0 .@0	1@1@3083 2@2@3084 3@3@3085 4@4@3086 5@5@3087 6@6@3088 7@7@3089 8@8@3090 9@9@3091 10@10@3092 11@11@3093 12@12@3094 13@13@3095 14@14@3096 15@15@3097 16@16@3098 17@17@3099 18@18@3100 19@19@3101 20@20@3102 21@21@3103 22@22@3104 23@23@3105 24@24@3106 25@25@3107 26@26@3108 27@27@3109 28@28@3110 29@29@3111 30@30@3112 31@31@3113 32@32@3114 33@33@3115 1@34@3116 2@35@3117 3@36@3118 4@37@3119 5@38@3120 6@39@3121 7@40@3122 8@41@3123 9@42@3124 10@43@3125 11@44@3126 12@45@3127 13@46@3128 14@47@3129 15@48@3130 16@49@3131 17@50@3132 18@51@3133 19@52@3134 20@53@3135 21@54@3136 22@55@3137 23@56@3138 24@57@3139 1@58@3140 2@59@3141 3@60@3142 4@61@3143 5@62@3144 6@63@3145 7@64@3146 8@65@3147 9@66@3148 10@67@3149 11@68@3150 12@69@3151 13@70@3152 14@71@3153 15@72@3154 1@73@3155 2@74@3156 3@75@3157 4@76@3158 5@77@3159 6@78@3160 7@79@3161 8@80@3162 9@81@3163 10@82@3164 11@83@3165 12@84@3166 13@85@3167 14@86@3168 15@87@3169 16@88@3170 17@89@3171 18@90@3172 19@91@3173 20@92@3174 21@93@3175 22@94@3176 23@95@3177 24@96@3178 25@97@3179 1@98@3180 2@99@3181 3@100@3182 4@101@3183 5@102@3184 6@103@3185 7@104@3186 8@105@3187 9@106@3188 10@107@3189 11@108@3190 12@109@3191 13@110@3192 14@111@3193 15@112@3194 16@113@3195 17@114@3196 18@115@3197	CD NN VBD NN IN DT NN IN JJ JJ NN NN VBD JJ NN IN DT NNS IN NN , NNP , CC JJ NN NN IN NNS IN JJ NN . DT NN IN CD JJ NNS VBD RB VBN TO VB JJ JJ NNS CC NN IN DT NN IN JJ JJ NNS . NN NN , NNS IN NN , NN CC JJ JJ NN VBD VBN . IN CD NNS IN NN , JJ NN RB VBD DT NNS IN NN , NN IN DT JJ NN NN , CC NNP . DT NN IN NNS IN NN , NNP , CC NN IN JJ JJ NNS VBD VBN .	nummod@2 nsubj@3 ROOT@0 nsubj@13 case@7 det@7 nmod:on@4 case@12 amod@12 amod@12 compound@12 nmod:of@7 ccomp@3 amod@15 dobj@13 case@18 det@18 nmod:of@15 case@20 nmod:of@18 punct@20 conj:and@20 punct@20 cc@20 amod@27 compound@27 conj:and@20 case@29 nmod:in@20 case@32 amod@32 nmod:with@29 punct@3 det:qmod@6 mwe@1 mwe@1 nummod@6 amod@6 nsubj:xsubj@11 auxpass@9 advmod@9 ROOT@0 mark@11 xcomp@9 amod@14 amod@14 dobj@11 cc@14 conj:or@14 case@19 det@19 nmod:on@11 case@23 amod@23 amod@23 nmod:of@19 punct@9 compound@2 nsubjpass@14 punct@2 appos@2 case@6 nmod:of@4 punct@6 conj:and@6 cc@6 amod@12 amod@12 conj:and@6 auxpass@14 ROOT@0 punct@14 case@3 nummod@3 nmod:after@10 case@5 nmod:of@3 punct@10 amod@8 nsubj@10 advmod@10 ROOT@0 det@12 dobj@10 case@14 nmod:of@12 punct@14 conj:and@14 case@21 det@21 amod@21 compound@21 nmod:of@16 punct@14 cc@14 conj:and@14 punct@10 neg@2 nsubjpass@17 case@4 nmod:on@2 case@6 nmod:of@4 punct@6 conj:or@6 punct@6 cc@6 conj:or@6 case@15 amod@15 amod@15 nmod:by@2 auxpass@17 ROOT@0 punct@17		c
